CT-defined body composition as a prognostic factor in multiple myeloma

A Surov, F Benkert, W Pönisch, HJ Meyer - Hematology, 2023 - Taylor & Francis
Objectives Body composition assessment is comprised by skeletal muscle mass (SMM) and
subcutaneous and visceral adipose tissue (SAT and VAT) and can be quantified by imaging …

Visceral adipose tissue glucose uptake is linked to prognosis in multiple myeloma patients: an exploratory study

AD da Cunha Júnior, MN Silveira, MES Takahashi… - Clinical Nutrition, 2021 - Elsevier
Background & aims The use of computerized tomography to opportunistically assess body
composition has highlighted abnormalities such as low muscle mass and high adiposity may …

Muscle and fat composition in patients with newly diagnosed multiple myeloma

NH Abdallah, H Nagayama, N Takahashi… - Blood cancer …, 2023 - nature.com
Measures of muscle and adipose tissue mass have been associated with outcomes in
several malignancies, but studies in multiple myeloma (MM) are inconsistent. The aim of this …

[HTML][HTML] Prehabilitation Exercise Training to Target Improved Muscle Strength in Pretransplant Patients Diagnosed With Multiple Myeloma: Protocol for a Pilot …

AJ Normann, CC Mo, RL Wilson… - JMIR Research …, 2024 - researchprotocols.org
Background Muscle mass and strength are severely compromised in patients diagnosed
with multiple myeloma, such that the risk of poor overall survival increases as the prevalence …

CT-defined muscle density as a prognostic factor in multiple myeloma undergoing autologous stem cell therapy: a retrospective single center study

A Surov, W Pönisch, J Borggrefe, HJ Meyer - Journal of Cancer Research …, 2024 - Springer
Purpose Skeletal muscle quality assessment can be performed by cross-sectional imaging.
Skeletal muscle density (SMD) identified to be of prognostic relevance of several clinically …

Sarcopenia and Myositis Revisited: Emerging Role of Fluorine-18 Fluorodeoxyglucose PET in Muscle Imaging

P Debs, A Al-Zaghal, LB Solnes, A Alavi - PET clinics, 2023 - pet.theclinics.com
Fluorine-18 fluorodeoxyglucose (FDG) is a glucose analog and the most used PET
radiopharmaceutical. Cellular uptake of FDG is determined by the expression of glucose …

[HTML][HTML] Prognostic value of low muscle mass at the 12th thoracic vertebral level in multiple myeloma treated with transplantation: CAREMM-2101 study

SS Park, D Kwag, JY Lee, YW Jeon… - Diagnostic and …, 2023 - ncbi.nlm.nih.gov
PURPOSE Autologous hematopoietic stem cell transplantation (ASCT) has been introduced
as a standard treatment for newly diagnosed multiple myeloma (NDMM) following novel …

ПЭТ-КТ при гематологических злокачественных опухолях: что достигнуто и к чему стремиться

АС Субботин, АИ Пронин… - Клиническая …, 2024 - bloodjournal.ru
ПЭТ-КТ стала неотъемлемым элементом ведения пациентов с большинством
гематологических злокачественных опухолей. Метод обеспечивает эффективное …

[引用][C] Otolog Hematopoietik Kök Hücre Nakli Yapılan Hastalarda BT/PET-BT ile Sarkopeni Varlığının Değerlendirilmesi ve Prognostik Öneminin Araştırılması

M Coşkunpınar - 2023 - Tıp Fakültesi